ESR1 and breast cancer: According to the expression of biomarkers, including estrogen receptors, progesterone receptors, human epidermal growth factor receptor 2 (HER2), and Ki67, BC mainly consists of luminal A, luminal B, HER-2 overexpression, and triple-negative breast cancer (TNBC) subtypes [3].